Search Medical Condition
Please enter condition
Please choose location

Hofu, Japan Clinical Trials

A listing of Hofu, Japan clinical trials actively recruiting patients volunteers.


Found (1) clinical trials

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

The maximum study duration per patient will be approximately 29 weeks: an up to 2-week screening period, a 26-week randomized open-label treatment period and a 3-day post-treatment safety follow up period.


0.0 miles

Learn More »